All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.
Checkpoint NOW
Claim This Podcastby Afreen Shariff
5.0(14 reviews)
34 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
16
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality12
Social0
YouTube0
Engagement51
Podcast Overview
All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.
Language
🇺🇲
Publishing Since
8/17/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
16
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality12
Social0
YouTube0
Engagement51
5
Excellent Areas
2
Good Performance
12
Growth Opportunities
excellent
Episode Length
23 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 53 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Checkpoint NOW
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 2, 2026
Type 1 Diabetes from Immune Checkpoint Inhibitors: What patients and caregivers need to know
<p>Guest expert, Onco Endocrinologist Dr. Melody Cheung, MD, PhD from Memorial Sloan Kettering Cancer Center joins hosts Dr. Afreen Shariff and Dr. Pauline Funchain to discuss Type 1 Diabetes, its diagnosis, consequences and what patients need to know about this new life changing diagnosis and how it impacts life and cancer treatments. Tune in to learn more. </p>
June 5, 2025
Episode 31: Journal Club: To re-challenge or not in refractory pneumonitis
Pulmonologist Dr. Kevin Ho and Medical Oncologist Dr. Aliyah Pabani explore the complexities of re-challenging refractory pneumonitis, analyzing key articles with host Dr. Afreen Shariff and guest host Dr. Pankti Reid in this interview.
May 16, 2025
Episode 31: Special Episode! Journal Club, Immune mediated pneumonitis.
<p>Join host Afreen Shariff, MD (Duke, Citrus Oncology) joined by guest host, rheumatologist, Dr. Pankti Reid (University of Chicago) as she leads a new format of CPN with medical oncologist, Dr. Aliyah Pabani (Johns Hopkins) and pulmonologist Dr. Kevin Ho (Ohio State). </p><p><br /></p><p>Articles: </p><p>https://pmc.ncbi.nlm.nih.gov/articles/PMC7797270/ (Balaji, et al, J Immunother Cancer. 2021)</p><p>https://pubmed.ncbi.nlm.nih.gov/33568350/ (Beattie, et al, J Immunother Cancer. 2021)</p>
34 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Checkpoint NOW
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Checkpoint NOW?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.